Journal article
Beta-Blocker therapy improves survival after concomitant septal myectomy and aortic valve replacement
Journal of cardiothoracic surgery, v 21(1), 118
19 Jan 2026
PMID: 41555403
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Background
The coexistence of hypertrophic obstructive cardiomyopathy (HOCM) and aortic stenosis (AS) often requires concomitant septal myectomy and aortic valve replacement (AVR). However, data on outcomes and medical management remain limited. This study investigates the impact of beta-blockers on long-term survival in patients undergoing concomitant septal myectomy and AVR.
Methods
We conducted a retrospective cohort study of 55 patients with moderate-to-severe AS and HCM who underwent myectomy and AVR at our center from 2007 to 2021. We evaluated baseline characteristics, postoperative data, and survival. Kaplan-Meier and Cox proportional hazards analyses identified predictors of survival.
Results
The mean age was 74 ± 8 years and 67% were female. Severe AS was present in 84% and 53% had HOCM. Cardiovascular risk factors were prevalent, including hypertension (80%), dyslipidemia (82%), and smoking history (53%). Postoperatively, 55% of patients experienced complications, including new-onset atrial fibrillation (35%) and complete heart block requiring permanent pacemaker implantation (33%). Beta-blocker use increased from 65% at admission to 84% at discharge. Median survival was 9.7 years, with 5-year and 8-year mortality rates of 22% and 49%, respectively, significantly lower than an age- and sex-matched control cohort (median survival 12.5 years). Beta-blockers were independently associated with improved survival (HR 0.27, 95% CI: 0.12–0.67) while smoking history predicted mortality (HR 4.07, 95% CI: 1.76–10.54).
Conclusion
Beta-blockers improved survival following septal myectomy and AVR while smoking history predicted mortality. Despite reduced outflow gradients, postoperative complications were common, emphasizing the need for improved treatment strategies. Further studies are needed to optimize postoperative management.
Metrics
2 Record Views
Details
- Title
- Beta-Blocker therapy improves survival after concomitant septal myectomy and aortic valve replacement
- Creators
- Preston So - Drexel University, College of MedicineMrinal Patel - University of PennsylvaniaAmit Iyengar - Hospital of the University of PennsylvaniaNoah Weingarten - University of PennsylvaniaJessica Dominic - University of PennsylvaniaAndrew Belec BA - University of PennsylvaniaJoyce Ho - University of PennsylvaniaPavan Atluri - Philadelphia, PA USA Division of Cardiovascular Surgery, Department of Surgery, Philadelphia, PA 19104 USA
- Publication Details
- Journal of cardiothoracic surgery, v 21(1), 118
- Publisher
- BMC
- Number of pages
- 9
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- College of Medicine
- Web of Science ID
- WOS:001706719400001
- Scopus ID
- 2-s2.0-105031966621
- Other Identifier
- 991022170457904721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
Source: SDGs in the Output
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Cardiac & Cardiovascular Systems
- Surgery